Global Oncology Injection Drug Market Research Report 2026(Status and Outlook)
An oncology injection drug refers to a medication administered by injection for the treatment of cancer. These drugs can be chemotherapy agents, targeted therapies, immunotherapies, or supportive medications.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Oncology Injection Drug market size was estimated at USD 183.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncology Injection Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncology Injection Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncology Injection Drug market.
Global Oncology Injection Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience
Market Segmentation (by Type)
Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other
Market Segmentation (by Application)
Lymphoma
Myeloma
Prostate Cancer
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncology Injection Drug Market
Overview of the regional outlook of the Oncology Injection Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Injection Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncology Injection Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Oncology Injection Drug market size was estimated at USD 183.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncology Injection Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncology Injection Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncology Injection Drug market.
Global Oncology Injection Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Taj Oncology
S.G. Biopharm
AdvaCare
Merrimack
Celgene
Allos Therapeutics
Ferring Pharmaceuticals
Genzyme
Eli Lilly
Praecis Pharmaceuticals
Millennium Pharmaceuticals
Debiopharm
Alza
CordenPharma
Pharmascience
Market Segmentation (by Type)
Organs
Central Nervous System
Circulatory/Musculoskeletal System
Other
Market Segmentation (by Application)
Lymphoma
Myeloma
Prostate Cancer
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncology Injection Drug Market
Overview of the regional outlook of the Oncology Injection Drug Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Injection Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncology Injection Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncology Injection Drug
1.2 Key Market Segments
1.2.1 Oncology Injection Drug Segment by Type
1.2.2 Oncology Injection Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY INJECTION DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Injection Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncology Injection Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY INJECTION DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncology Injection Drug Product Life Cycle
3.3 Global Oncology Injection Drug Sales by Manufacturers (2020-2025)
3.4 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncology Injection Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncology Injection Drug Market Competitive Situation and Trends
3.8.1 Oncology Injection Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncology Injection Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY INJECTION DRUG INDUSTRY CHAIN ANALYSIS
4.1 Oncology Injection Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY INJECTION DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncology Injection Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncology Injection Drug Market
5.7 ESG Ratings of Leading Companies
6 ONCOLOGY INJECTION DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Injection Drug Sales Market Share by Type (2020-2025)
6.3 Global Oncology Injection Drug Market Size by Type (2020-2025)
6.4 Global Oncology Injection Drug Price by Type (2020-2025)
7 ONCOLOGY INJECTION DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Injection Drug Market Sales by Application (2020-2025)
7.3 Global Oncology Injection Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Oncology Injection Drug Sales Growth Rate by Application (2020-2025)
8 ONCOLOGY INJECTION DRUG MARKET SALES BY REGION
8.1 Global Oncology Injection Drug Sales by Region
8.1.1 Global Oncology Injection Drug Sales by Region
8.1.2 Global Oncology Injection Drug Sales Market Share by Region
8.2 Global Oncology Injection Drug Market Size by Region
8.2.1 Global Oncology Injection Drug Market Size by Region
8.2.2 Global Oncology Injection Drug Market Size by Region
8.3 North America
8.3.1 North America Oncology Injection Drug Sales by Country
8.3.2 North America Oncology Injection Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncology Injection Drug Sales by Country
8.4.2 Europe Oncology Injection Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncology Injection Drug Sales by Region
8.5.2 Asia Pacific Oncology Injection Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncology Injection Drug Sales by Country
8.6.2 South America Oncology Injection Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncology Injection Drug Sales by Region
8.7.2 Middle East and Africa Oncology Injection Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLOGY INJECTION DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Oncology Injection Drug by Region(2020-2025)
9.2 Global Oncology Injection Drug Revenue Market Share by Region (2020-2025)
9.3 Global Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncology Injection Drug Production
9.4.1 North America Oncology Injection Drug Production Growth Rate (2020-2025)
9.4.2 North America Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncology Injection Drug Production
9.5.1 Europe Oncology Injection Drug Production Growth Rate (2020-2025)
9.5.2 Europe Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncology Injection Drug Production (2020-2025)
9.6.1 Japan Oncology Injection Drug Production Growth Rate (2020-2025)
9.6.2 Japan Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncology Injection Drug Production (2020-2025)
9.7.1 China Oncology Injection Drug Production Growth Rate (2020-2025)
9.7.2 China Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Taj Oncology
10.1.1 Taj Oncology Basic Information
10.1.2 Taj Oncology Oncology Injection Drug Product Overview
10.1.3 Taj Oncology Oncology Injection Drug Product Market Performance
10.1.4 Taj Oncology Business Overview
10.1.5 Taj Oncology SWOT Analysis
10.1.6 Taj Oncology Recent Developments
10.2 S.G. Biopharm
10.2.1 S.G. Biopharm Basic Information
10.2.2 S.G. Biopharm Oncology Injection Drug Product Overview
10.2.3 S.G. Biopharm Oncology Injection Drug Product Market Performance
10.2.4 S.G. Biopharm Business Overview
10.2.5 S.G. Biopharm SWOT Analysis
10.2.6 S.G. Biopharm Recent Developments
10.3 AdvaCare
10.3.1 AdvaCare Basic Information
10.3.2 AdvaCare Oncology Injection Drug Product Overview
10.3.3 AdvaCare Oncology Injection Drug Product Market Performance
10.3.4 AdvaCare Business Overview
10.3.5 AdvaCare SWOT Analysis
10.3.6 AdvaCare Recent Developments
10.4 Merrimack
10.4.1 Merrimack Basic Information
10.4.2 Merrimack Oncology Injection Drug Product Overview
10.4.3 Merrimack Oncology Injection Drug Product Market Performance
10.4.4 Merrimack Business Overview
10.4.5 Merrimack Recent Developments
10.5 Celgene
10.5.1 Celgene Basic Information
10.5.2 Celgene Oncology Injection Drug Product Overview
10.5.3 Celgene Oncology Injection Drug Product Market Performance
10.5.4 Celgene Business Overview
10.5.5 Celgene Recent Developments
10.6 Allos Therapeutics
10.6.1 Allos Therapeutics Basic Information
10.6.2 Allos Therapeutics Oncology Injection Drug Product Overview
10.6.3 Allos Therapeutics Oncology Injection Drug Product Market Performance
10.6.4 Allos Therapeutics Business Overview
10.6.5 Allos Therapeutics Recent Developments
10.7 Ferring Pharmaceuticals
10.7.1 Ferring Pharmaceuticals Basic Information
10.7.2 Ferring Pharmaceuticals Oncology Injection Drug Product Overview
10.7.3 Ferring Pharmaceuticals Oncology Injection Drug Product Market Performance
10.7.4 Ferring Pharmaceuticals Business Overview
10.7.5 Ferring Pharmaceuticals Recent Developments
10.8 Genzyme
10.8.1 Genzyme Basic Information
10.8.2 Genzyme Oncology Injection Drug Product Overview
10.8.3 Genzyme Oncology Injection Drug Product Market Performance
10.8.4 Genzyme Business Overview
10.8.5 Genzyme Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Basic Information
10.9.2 Eli Lilly Oncology Injection Drug Product Overview
10.9.3 Eli Lilly Oncology Injection Drug Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 Praecis Pharmaceuticals
10.10.1 Praecis Pharmaceuticals Basic Information
10.10.2 Praecis Pharmaceuticals Oncology Injection Drug Product Overview
10.10.3 Praecis Pharmaceuticals Oncology Injection Drug Product Market Performance
10.10.4 Praecis Pharmaceuticals Business Overview
10.10.5 Praecis Pharmaceuticals Recent Developments
10.11 Millennium Pharmaceuticals
10.11.1 Millennium Pharmaceuticals Basic Information
10.11.2 Millennium Pharmaceuticals Oncology Injection Drug Product Overview
10.11.3 Millennium Pharmaceuticals Oncology Injection Drug Product Market Performance
10.11.4 Millennium Pharmaceuticals Business Overview
10.11.5 Millennium Pharmaceuticals Recent Developments
10.12 Debiopharm
10.12.1 Debiopharm Basic Information
10.12.2 Debiopharm Oncology Injection Drug Product Overview
10.12.3 Debiopharm Oncology Injection Drug Product Market Performance
10.12.4 Debiopharm Business Overview
10.12.5 Debiopharm Recent Developments
10.13 Alza
10.13.1 Alza Basic Information
10.13.2 Alza Oncology Injection Drug Product Overview
10.13.3 Alza Oncology Injection Drug Product Market Performance
10.13.4 Alza Business Overview
10.13.5 Alza Recent Developments
10.14 CordenPharma
10.14.1 CordenPharma Basic Information
10.14.2 CordenPharma Oncology Injection Drug Product Overview
10.14.3 CordenPharma Oncology Injection Drug Product Market Performance
10.14.4 CordenPharma Business Overview
10.14.5 CordenPharma Recent Developments
10.15 Pharmascience
10.15.1 Pharmascience Basic Information
10.15.2 Pharmascience Oncology Injection Drug Product Overview
10.15.3 Pharmascience Oncology Injection Drug Product Market Performance
10.15.4 Pharmascience Business Overview
10.15.5 Pharmascience Recent Developments
11 ONCOLOGY INJECTION DRUG MARKET FORECAST BY REGION
11.1 Global Oncology Injection Drug Market Size Forecast
11.2 Global Oncology Injection Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Injection Drug Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Injection Drug Market Size Forecast by Region
11.2.4 South America Oncology Injection Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncology Injection Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncology Injection Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncology Injection Drug by Type (2026-2035)
12.1.2 Global Oncology Injection Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncology Injection Drug by Type (2026-2035)
12.2 Global Oncology Injection Drug Market Forecast by Application (2026-2035)
12.2.1 Global Oncology Injection Drug Sales (K MT) Forecast by Application
12.2.2 Global Oncology Injection Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncology Injection Drug
1.2 Key Market Segments
1.2.1 Oncology Injection Drug Segment by Type
1.2.2 Oncology Injection Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY INJECTION DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Injection Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncology Injection Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY INJECTION DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncology Injection Drug Product Life Cycle
3.3 Global Oncology Injection Drug Sales by Manufacturers (2020-2025)
3.4 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncology Injection Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncology Injection Drug Market Competitive Situation and Trends
3.8.1 Oncology Injection Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncology Injection Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY INJECTION DRUG INDUSTRY CHAIN ANALYSIS
4.1 Oncology Injection Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY INJECTION DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncology Injection Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncology Injection Drug Market
5.7 ESG Ratings of Leading Companies
6 ONCOLOGY INJECTION DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Injection Drug Sales Market Share by Type (2020-2025)
6.3 Global Oncology Injection Drug Market Size by Type (2020-2025)
6.4 Global Oncology Injection Drug Price by Type (2020-2025)
7 ONCOLOGY INJECTION DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Injection Drug Market Sales by Application (2020-2025)
7.3 Global Oncology Injection Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Oncology Injection Drug Sales Growth Rate by Application (2020-2025)
8 ONCOLOGY INJECTION DRUG MARKET SALES BY REGION
8.1 Global Oncology Injection Drug Sales by Region
8.1.1 Global Oncology Injection Drug Sales by Region
8.1.2 Global Oncology Injection Drug Sales Market Share by Region
8.2 Global Oncology Injection Drug Market Size by Region
8.2.1 Global Oncology Injection Drug Market Size by Region
8.2.2 Global Oncology Injection Drug Market Size by Region
8.3 North America
8.3.1 North America Oncology Injection Drug Sales by Country
8.3.2 North America Oncology Injection Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncology Injection Drug Sales by Country
8.4.2 Europe Oncology Injection Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncology Injection Drug Sales by Region
8.5.2 Asia Pacific Oncology Injection Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncology Injection Drug Sales by Country
8.6.2 South America Oncology Injection Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncology Injection Drug Sales by Region
8.7.2 Middle East and Africa Oncology Injection Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLOGY INJECTION DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Oncology Injection Drug by Region(2020-2025)
9.2 Global Oncology Injection Drug Revenue Market Share by Region (2020-2025)
9.3 Global Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncology Injection Drug Production
9.4.1 North America Oncology Injection Drug Production Growth Rate (2020-2025)
9.4.2 North America Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncology Injection Drug Production
9.5.1 Europe Oncology Injection Drug Production Growth Rate (2020-2025)
9.5.2 Europe Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncology Injection Drug Production (2020-2025)
9.6.1 Japan Oncology Injection Drug Production Growth Rate (2020-2025)
9.6.2 Japan Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncology Injection Drug Production (2020-2025)
9.7.1 China Oncology Injection Drug Production Growth Rate (2020-2025)
9.7.2 China Oncology Injection Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Taj Oncology
10.1.1 Taj Oncology Basic Information
10.1.2 Taj Oncology Oncology Injection Drug Product Overview
10.1.3 Taj Oncology Oncology Injection Drug Product Market Performance
10.1.4 Taj Oncology Business Overview
10.1.5 Taj Oncology SWOT Analysis
10.1.6 Taj Oncology Recent Developments
10.2 S.G. Biopharm
10.2.1 S.G. Biopharm Basic Information
10.2.2 S.G. Biopharm Oncology Injection Drug Product Overview
10.2.3 S.G. Biopharm Oncology Injection Drug Product Market Performance
10.2.4 S.G. Biopharm Business Overview
10.2.5 S.G. Biopharm SWOT Analysis
10.2.6 S.G. Biopharm Recent Developments
10.3 AdvaCare
10.3.1 AdvaCare Basic Information
10.3.2 AdvaCare Oncology Injection Drug Product Overview
10.3.3 AdvaCare Oncology Injection Drug Product Market Performance
10.3.4 AdvaCare Business Overview
10.3.5 AdvaCare SWOT Analysis
10.3.6 AdvaCare Recent Developments
10.4 Merrimack
10.4.1 Merrimack Basic Information
10.4.2 Merrimack Oncology Injection Drug Product Overview
10.4.3 Merrimack Oncology Injection Drug Product Market Performance
10.4.4 Merrimack Business Overview
10.4.5 Merrimack Recent Developments
10.5 Celgene
10.5.1 Celgene Basic Information
10.5.2 Celgene Oncology Injection Drug Product Overview
10.5.3 Celgene Oncology Injection Drug Product Market Performance
10.5.4 Celgene Business Overview
10.5.5 Celgene Recent Developments
10.6 Allos Therapeutics
10.6.1 Allos Therapeutics Basic Information
10.6.2 Allos Therapeutics Oncology Injection Drug Product Overview
10.6.3 Allos Therapeutics Oncology Injection Drug Product Market Performance
10.6.4 Allos Therapeutics Business Overview
10.6.5 Allos Therapeutics Recent Developments
10.7 Ferring Pharmaceuticals
10.7.1 Ferring Pharmaceuticals Basic Information
10.7.2 Ferring Pharmaceuticals Oncology Injection Drug Product Overview
10.7.3 Ferring Pharmaceuticals Oncology Injection Drug Product Market Performance
10.7.4 Ferring Pharmaceuticals Business Overview
10.7.5 Ferring Pharmaceuticals Recent Developments
10.8 Genzyme
10.8.1 Genzyme Basic Information
10.8.2 Genzyme Oncology Injection Drug Product Overview
10.8.3 Genzyme Oncology Injection Drug Product Market Performance
10.8.4 Genzyme Business Overview
10.8.5 Genzyme Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Basic Information
10.9.2 Eli Lilly Oncology Injection Drug Product Overview
10.9.3 Eli Lilly Oncology Injection Drug Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 Praecis Pharmaceuticals
10.10.1 Praecis Pharmaceuticals Basic Information
10.10.2 Praecis Pharmaceuticals Oncology Injection Drug Product Overview
10.10.3 Praecis Pharmaceuticals Oncology Injection Drug Product Market Performance
10.10.4 Praecis Pharmaceuticals Business Overview
10.10.5 Praecis Pharmaceuticals Recent Developments
10.11 Millennium Pharmaceuticals
10.11.1 Millennium Pharmaceuticals Basic Information
10.11.2 Millennium Pharmaceuticals Oncology Injection Drug Product Overview
10.11.3 Millennium Pharmaceuticals Oncology Injection Drug Product Market Performance
10.11.4 Millennium Pharmaceuticals Business Overview
10.11.5 Millennium Pharmaceuticals Recent Developments
10.12 Debiopharm
10.12.1 Debiopharm Basic Information
10.12.2 Debiopharm Oncology Injection Drug Product Overview
10.12.3 Debiopharm Oncology Injection Drug Product Market Performance
10.12.4 Debiopharm Business Overview
10.12.5 Debiopharm Recent Developments
10.13 Alza
10.13.1 Alza Basic Information
10.13.2 Alza Oncology Injection Drug Product Overview
10.13.3 Alza Oncology Injection Drug Product Market Performance
10.13.4 Alza Business Overview
10.13.5 Alza Recent Developments
10.14 CordenPharma
10.14.1 CordenPharma Basic Information
10.14.2 CordenPharma Oncology Injection Drug Product Overview
10.14.3 CordenPharma Oncology Injection Drug Product Market Performance
10.14.4 CordenPharma Business Overview
10.14.5 CordenPharma Recent Developments
10.15 Pharmascience
10.15.1 Pharmascience Basic Information
10.15.2 Pharmascience Oncology Injection Drug Product Overview
10.15.3 Pharmascience Oncology Injection Drug Product Market Performance
10.15.4 Pharmascience Business Overview
10.15.5 Pharmascience Recent Developments
11 ONCOLOGY INJECTION DRUG MARKET FORECAST BY REGION
11.1 Global Oncology Injection Drug Market Size Forecast
11.2 Global Oncology Injection Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncology Injection Drug Market Size Forecast by Country
11.2.3 Asia Pacific Oncology Injection Drug Market Size Forecast by Region
11.2.4 South America Oncology Injection Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncology Injection Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncology Injection Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncology Injection Drug by Type (2026-2035)
12.1.2 Global Oncology Injection Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncology Injection Drug by Type (2026-2035)
12.2 Global Oncology Injection Drug Market Forecast by Application (2026-2035)
12.2.1 Global Oncology Injection Drug Sales (K MT) Forecast by Application
12.2.2 Global Oncology Injection Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncology Injection Drug Market Size by Type (M USD)
Table 4. Global Oncology Injection Drug Market Size by Application
Table 5. Oncology Injection Drug Market Size Comparison by Region (M USD)
Table 6. Global Oncology Injection Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oncology Injection Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncology Injection Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncology Injection Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2025)
Table 11. Global Market Oncology Injection Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Injection Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncology Injection Drug Sales by Type (K MT)
Table 27. Global Oncology Injection Drug Market Size by Type (M USD)
Table 28. Global Oncology Injection Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Oncology Injection Drug Sales Market Share by Type (2020-2025)
Table 30. Global Oncology Injection Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncology Injection Drug Market Share by Type (2020-2025)
Table 32. Global Oncology Injection Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Oncology Injection Drug Sales (K MT) by Application
Table 34. Global Oncology Injection Drug Market Size by Application
Table 35. Global Oncology Injection Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Oncology Injection Drug Sales Market Share by Application (2020-2025)
Table 37. Global Oncology Injection Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncology Injection Drug Market Share by Application (2020-2025)
Table 39. Global Oncology Injection Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncology Injection Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Oncology Injection Drug Sales Market Share by Region (2020-2025)
Table 42. Global Oncology Injection Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncology Injection Drug Market Size by Region (2020-2025)
Table 44. North America Oncology Injection Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Oncology Injection Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncology Injection Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oncology Injection Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncology Injection Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oncology Injection Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncology Injection Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Oncology Injection Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncology Injection Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oncology Injection Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncology Injection Drug Production (K MT) by Region(2020-2025)
Table 55. Global Oncology Injection Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncology Injection Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Taj Oncology Basic Information
Table 63. Taj Oncology Oncology Injection Drug Product Overview
Table 64. Taj Oncology Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Taj Oncology Business Overview
Table 66. Taj Oncology SWOT Analysis
Table 67. Taj Oncology Recent Developments
Table 68. S.G. Biopharm Basic Information
Table 69. S.G. Biopharm Oncology Injection Drug Product Overview
Table 70. S.G. Biopharm Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. S.G. Biopharm Business Overview
Table 72. S.G. Biopharm SWOT Analysis
Table 73. S.G. Biopharm Recent Developments
Table 74. AdvaCare Basic Information
Table 75. AdvaCare Oncology Injection Drug Product Overview
Table 76. AdvaCare Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. AdvaCare Business Overview
Table 78. AdvaCare SWOT Analysis
Table 79. AdvaCare Recent Developments
Table 80. Merrimack Basic Information
Table 81. Merrimack Oncology Injection Drug Product Overview
Table 82. Merrimack Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Merrimack Business Overview
Table 84. Merrimack Recent Developments
Table 85. Celgene Basic Information
Table 86. Celgene Oncology Injection Drug Product Overview
Table 87. Celgene Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Celgene Business Overview
Table 89. Celgene Recent Developments
Table 90. Allos Therapeutics Basic Information
Table 91. Allos Therapeutics Oncology Injection Drug Product Overview
Table 92. Allos Therapeutics Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Allos Therapeutics Business Overview
Table 94. Allos Therapeutics Recent Developments
Table 95. Ferring Pharmaceuticals Basic Information
Table 96. Ferring Pharmaceuticals Oncology Injection Drug Product Overview
Table 97. Ferring Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Ferring Pharmaceuticals Business Overview
Table 99. Ferring Pharmaceuticals Recent Developments
Table 100. Genzyme Basic Information
Table 101. Genzyme Oncology Injection Drug Product Overview
Table 102. Genzyme Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Genzyme Business Overview
Table 104. Genzyme Recent Developments
Table 105. Eli Lilly Basic Information
Table 106. Eli Lilly Oncology Injection Drug Product Overview
Table 107. Eli Lilly Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Eli Lilly Business Overview
Table 109. Eli Lilly Recent Developments
Table 110. Praecis Pharmaceuticals Basic Information
Table 111. Praecis Pharmaceuticals Oncology Injection Drug Product Overview
Table 112. Praecis Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Praecis Pharmaceuticals Business Overview
Table 114. Praecis Pharmaceuticals Recent Developments
Table 115. Millennium Pharmaceuticals Basic Information
Table 116. Millennium Pharmaceuticals Oncology Injection Drug Product Overview
Table 117. Millennium Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Millennium Pharmaceuticals Business Overview
Table 119. Millennium Pharmaceuticals Recent Developments
Table 120. Debiopharm Basic Information
Table 121. Debiopharm Oncology Injection Drug Product Overview
Table 122. Debiopharm Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Debiopharm Business Overview
Table 124. Debiopharm Recent Developments
Table 125. Alza Basic Information
Table 126. Alza Oncology Injection Drug Product Overview
Table 127. Alza Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Alza Business Overview
Table 129. Alza Recent Developments
Table 130. CordenPharma Basic Information
Table 131. CordenPharma Oncology Injection Drug Product Overview
Table 132. CordenPharma Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. CordenPharma Business Overview
Table 134. CordenPharma Recent Developments
Table 135. Pharmascience Basic Information
Table 136. Pharmascience Oncology Injection Drug Product Overview
Table 137. Pharmascience Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Pharmascience Business Overview
Table 139. Pharmascience Recent Developments
Table 140. Global Oncology Injection Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Oncology Injection Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Oncology Injection Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Oncology Injection Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Oncology Injection Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Oncology Injection Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Oncology Injection Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Oncology Injection Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Oncology Injection Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Oncology Injection Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Oncology Injection Drug Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Oncology Injection Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Oncology Injection Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Oncology Injection Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Oncology Injection Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Oncology Injection Drug Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Oncology Injection Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncology Injection Drug Market Size by Type (M USD)
Table 4. Global Oncology Injection Drug Market Size by Application
Table 5. Oncology Injection Drug Market Size Comparison by Region (M USD)
Table 6. Global Oncology Injection Drug Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oncology Injection Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncology Injection Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncology Injection Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Injection Drug as of 2025)
Table 11. Global Market Oncology Injection Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncology Injection Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Injection Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncology Injection Drug Sales by Type (K MT)
Table 27. Global Oncology Injection Drug Market Size by Type (M USD)
Table 28. Global Oncology Injection Drug Sales (K MT) by Type (2020-2025)
Table 29. Global Oncology Injection Drug Sales Market Share by Type (2020-2025)
Table 30. Global Oncology Injection Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncology Injection Drug Market Share by Type (2020-2025)
Table 32. Global Oncology Injection Drug Price (USD/KG) by Type (2020-2025)
Table 33. Global Oncology Injection Drug Sales (K MT) by Application
Table 34. Global Oncology Injection Drug Market Size by Application
Table 35. Global Oncology Injection Drug Sales by Application (2020-2025) & (K MT)
Table 36. Global Oncology Injection Drug Sales Market Share by Application (2020-2025)
Table 37. Global Oncology Injection Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncology Injection Drug Market Share by Application (2020-2025)
Table 39. Global Oncology Injection Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncology Injection Drug Sales by Region (2020-2025) & (K MT)
Table 41. Global Oncology Injection Drug Sales Market Share by Region (2020-2025)
Table 42. Global Oncology Injection Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncology Injection Drug Market Size by Region (2020-2025)
Table 44. North America Oncology Injection Drug Sales by Country (2020-2025) & (K MT)
Table 45. North America Oncology Injection Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncology Injection Drug Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oncology Injection Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncology Injection Drug Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oncology Injection Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncology Injection Drug Sales by Country (2020-2025) & (K MT)
Table 51. South America Oncology Injection Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncology Injection Drug Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oncology Injection Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncology Injection Drug Production (K MT) by Region(2020-2025)
Table 55. Global Oncology Injection Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncology Injection Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oncology Injection Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Taj Oncology Basic Information
Table 63. Taj Oncology Oncology Injection Drug Product Overview
Table 64. Taj Oncology Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Taj Oncology Business Overview
Table 66. Taj Oncology SWOT Analysis
Table 67. Taj Oncology Recent Developments
Table 68. S.G. Biopharm Basic Information
Table 69. S.G. Biopharm Oncology Injection Drug Product Overview
Table 70. S.G. Biopharm Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. S.G. Biopharm Business Overview
Table 72. S.G. Biopharm SWOT Analysis
Table 73. S.G. Biopharm Recent Developments
Table 74. AdvaCare Basic Information
Table 75. AdvaCare Oncology Injection Drug Product Overview
Table 76. AdvaCare Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. AdvaCare Business Overview
Table 78. AdvaCare SWOT Analysis
Table 79. AdvaCare Recent Developments
Table 80. Merrimack Basic Information
Table 81. Merrimack Oncology Injection Drug Product Overview
Table 82. Merrimack Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Merrimack Business Overview
Table 84. Merrimack Recent Developments
Table 85. Celgene Basic Information
Table 86. Celgene Oncology Injection Drug Product Overview
Table 87. Celgene Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Celgene Business Overview
Table 89. Celgene Recent Developments
Table 90. Allos Therapeutics Basic Information
Table 91. Allos Therapeutics Oncology Injection Drug Product Overview
Table 92. Allos Therapeutics Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Allos Therapeutics Business Overview
Table 94. Allos Therapeutics Recent Developments
Table 95. Ferring Pharmaceuticals Basic Information
Table 96. Ferring Pharmaceuticals Oncology Injection Drug Product Overview
Table 97. Ferring Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Ferring Pharmaceuticals Business Overview
Table 99. Ferring Pharmaceuticals Recent Developments
Table 100. Genzyme Basic Information
Table 101. Genzyme Oncology Injection Drug Product Overview
Table 102. Genzyme Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Genzyme Business Overview
Table 104. Genzyme Recent Developments
Table 105. Eli Lilly Basic Information
Table 106. Eli Lilly Oncology Injection Drug Product Overview
Table 107. Eli Lilly Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Eli Lilly Business Overview
Table 109. Eli Lilly Recent Developments
Table 110. Praecis Pharmaceuticals Basic Information
Table 111. Praecis Pharmaceuticals Oncology Injection Drug Product Overview
Table 112. Praecis Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Praecis Pharmaceuticals Business Overview
Table 114. Praecis Pharmaceuticals Recent Developments
Table 115. Millennium Pharmaceuticals Basic Information
Table 116. Millennium Pharmaceuticals Oncology Injection Drug Product Overview
Table 117. Millennium Pharmaceuticals Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Millennium Pharmaceuticals Business Overview
Table 119. Millennium Pharmaceuticals Recent Developments
Table 120. Debiopharm Basic Information
Table 121. Debiopharm Oncology Injection Drug Product Overview
Table 122. Debiopharm Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Debiopharm Business Overview
Table 124. Debiopharm Recent Developments
Table 125. Alza Basic Information
Table 126. Alza Oncology Injection Drug Product Overview
Table 127. Alza Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Alza Business Overview
Table 129. Alza Recent Developments
Table 130. CordenPharma Basic Information
Table 131. CordenPharma Oncology Injection Drug Product Overview
Table 132. CordenPharma Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. CordenPharma Business Overview
Table 134. CordenPharma Recent Developments
Table 135. Pharmascience Basic Information
Table 136. Pharmascience Oncology Injection Drug Product Overview
Table 137. Pharmascience Oncology Injection Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Pharmascience Business Overview
Table 139. Pharmascience Recent Developments
Table 140. Global Oncology Injection Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 141. Global Oncology Injection Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 142. North America Oncology Injection Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 143. North America Oncology Injection Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 144. Europe Oncology Injection Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 145. Europe Oncology Injection Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 146. Asia Pacific Oncology Injection Drug Sales Forecast by Region (2026-2035) & (K MT)
Table 147. Asia Pacific Oncology Injection Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 148. South America Oncology Injection Drug Sales Forecast by Country (2026-2035) & (K MT)
Table 149. South America Oncology Injection Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 150. Middle East and Africa Oncology Injection Drug Sales Forecast by Country (2026-2035) & (Units)
Table 151. Middle East and Africa Oncology Injection Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 152. Global Oncology Injection Drug Sales Forecast by Type (2026-2035) & (K MT)
Table 153. Global Oncology Injection Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 154. Global Oncology Injection Drug Price Forecast by Type (2026-2035) & (USD/KG)
Table 155. Global Oncology Injection Drug Sales (K MT) Forecast by Application (2026-2035)
Table 156. Global Oncology Injection Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncology Injection Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Injection Drug Market Size (M USD), 2025-2035
Figure 5. Global Oncology Injection Drug Market Size (M USD) (2020-2035)
Figure 6. Global Oncology Injection Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Injection Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncology Injection Drug Product Life Cycle
Figure 13. Oncology Injection Drug Sales Share by Manufacturers in 2025
Figure 14. Global Oncology Injection Drug Revenue Share by Manufacturers in 2025
Figure 15. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncology Injection Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncology Injection Drug Revenue in 2025
Figure 18. Industry Chain Map of Oncology Injection Drug
Figure 19. Global Oncology Injection Drug Market PEST Analysis
Figure 20. Global Oncology Injection Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncology Injection Drug Market Share by Type
Figure 27. Sales Market Share of Oncology Injection Drug by Type (2020-2025)
Figure 28. Sales Market Share of Oncology Injection Drug by Type in 2025
Figure 29. Market Share of Oncology Injection Drug by Type (2020-2025)
Figure 30. Market Share of Oncology Injection Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncology Injection Drug Market Share by Application
Figure 33. Global Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Oncology Injection Drug Sales Market Share by Application in 2025
Figure 35. Global Oncology Injection Drug Market Share by Application (2020-2025)
Figure 36. Global Oncology Injection Drug Market Share by Application in 2025
Figure 37. Global Oncology Injection Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncology Injection Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Oncology Injection Drug Market Size by Region (2020-2025)
Figure 40. North America Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oncology Injection Drug Sales Market Share by Country in 2024
Figure 43. North America Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncology Injection Drug Market Size by Country in 2024
Figure 45. U.S. Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncology Injection Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oncology Injection Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncology Injection Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncology Injection Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oncology Injection Drug Sales Market Share by Country in 2024
Figure 53. Europe Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncology Injection Drug Market Size by Country in 2024
Figure 55. Germany Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oncology Injection Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncology Injection Drug Market Size by Region in 2024
Figure 68. China Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 79. South America Oncology Injection Drug Sales Market Share by Country in 2024
Figure 80. South America Oncology Injection Drug Market Size and Growth Rate (M USD)
Figure 81. South America Oncology Injection Drug Market Size by Country in 2024
Figure 82. Brazil Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oncology Injection Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncology Injection Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncology Injection Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncology Injection Drug Production Market Share by Region (2020-2025)
Figure 103. North America Oncology Injection Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oncology Injection Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oncology Injection Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oncology Injection Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oncology Injection Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oncology Injection Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncology Injection Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncology Injection Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncology Injection Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Oncology Injection Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Oncology Injection Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Injection Drug Market Size (M USD), 2025-2035
Figure 5. Global Oncology Injection Drug Market Size (M USD) (2020-2035)
Figure 6. Global Oncology Injection Drug Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Injection Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncology Injection Drug Product Life Cycle
Figure 13. Oncology Injection Drug Sales Share by Manufacturers in 2025
Figure 14. Global Oncology Injection Drug Revenue Share by Manufacturers in 2025
Figure 15. Oncology Injection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncology Injection Drug Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncology Injection Drug Revenue in 2025
Figure 18. Industry Chain Map of Oncology Injection Drug
Figure 19. Global Oncology Injection Drug Market PEST Analysis
Figure 20. Global Oncology Injection Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncology Injection Drug Market Share by Type
Figure 27. Sales Market Share of Oncology Injection Drug by Type (2020-2025)
Figure 28. Sales Market Share of Oncology Injection Drug by Type in 2025
Figure 29. Market Share of Oncology Injection Drug by Type (2020-2025)
Figure 30. Market Share of Oncology Injection Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncology Injection Drug Market Share by Application
Figure 33. Global Oncology Injection Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Oncology Injection Drug Sales Market Share by Application in 2025
Figure 35. Global Oncology Injection Drug Market Share by Application (2020-2025)
Figure 36. Global Oncology Injection Drug Market Share by Application in 2025
Figure 37. Global Oncology Injection Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncology Injection Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Oncology Injection Drug Market Size by Region (2020-2025)
Figure 40. North America Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oncology Injection Drug Sales Market Share by Country in 2024
Figure 43. North America Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncology Injection Drug Market Size by Country in 2024
Figure 45. U.S. Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncology Injection Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oncology Injection Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncology Injection Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncology Injection Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oncology Injection Drug Sales Market Share by Country in 2024
Figure 53. Europe Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncology Injection Drug Market Size by Country in 2024
Figure 55. Germany Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oncology Injection Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncology Injection Drug Market Size by Region in 2024
Figure 68. China Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 79. South America Oncology Injection Drug Sales Market Share by Country in 2024
Figure 80. South America Oncology Injection Drug Market Size and Growth Rate (M USD)
Figure 81. South America Oncology Injection Drug Market Size by Country in 2024
Figure 82. Brazil Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncology Injection Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oncology Injection Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncology Injection Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncology Injection Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncology Injection Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oncology Injection Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncology Injection Drug Production Market Share by Region (2020-2025)
Figure 103. North America Oncology Injection Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oncology Injection Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oncology Injection Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oncology Injection Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oncology Injection Drug Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oncology Injection Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncology Injection Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncology Injection Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncology Injection Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Oncology Injection Drug Market Share Forecast by Application (2026-2035)
